Cytek Biosciences, Inc. Common Stock (CTKB)
Cytek Biosciences, Inc. is a biotechnology company specializing in developing and manufacturing advanced spectral flow cytometry instruments. Founded to improve cellular analysis, it offers innovative solutions for research and clinical laboratories, enabling detailed immune profiling and cellular characterization through high-parameter, multicolor flow cytometry systems.
Company News
Cytek Biosciences relocates and expands its European headquarters in Amsterdam, increasing its facility footprint by over 40% and establishing a dedicated customer service and training center to strengthen its presence in the EMEA region.
Cytek Biosciences (CTKB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ: TSLA) fell during Monday’s session after the company reportedly saw a decline in February China sales. Tesla sold 60,365 electric vehicles made in China in February, according to preliminary data released by the China Passenger ...
Cytek grew revenue and losses in the first quarter.